KB
AGN

Kimelman & Baird’s Allergan Inc AGN Stock Holding History

Kimelman & Baird’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,000
Closed -$425K – 117
2014
Q4 		$425K Hold
2,000
– – 0.08% 88
2014
Q3 		$356K Hold
2,000
– – 0.07% 92
2014
Q2 		$338K Hold
2,000
– – 0.06% 94
2014
Q1 		$248K Buy
+2,000
New +$244K 0.05% 95

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Kimelman & Baird's AGN Position: Q1 2015 in Review

Kimelman & Baird sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,000 shares — an estimated $425K sold.

Kimelman & Baird first reported a position in AGN in Q1 2014 and held it in 4 quarters. The position peaked at $425K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Kimelman & Baird reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Kimelman & Baird sold 2,000 Allergan Inc shares in Q1 2015, an estimated $425K.
  • Kimelman & Baird first reported a position in Allergan Inc in Q1 2014 and held it in 4 quarters.
  • Kimelman & Baird's Allergan Inc position peaked at $425K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Kimelman & Baird's 13F filing for Q1 2015, filed 12 May 2015.